These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27490392)

  • 1. Virtual Screening for HIV Protease Inhibitors Using a Novel Database Filtering Procedure.
    Takkis K; García-Sosa AT; Sild S
    Mol Inform; 2015 Jun; 34(6-7):485-92. PubMed ID: 27490392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel HIV 1--protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening.
    Yadav D; Paliwal S; Yadav R; Pal M; Pandey A
    PLoS One; 2012; 7(11):e48942. PubMed ID: 23145032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient molecular docking of NMR structures: application to HIV-1 protease.
    Huang SY; Zou X
    Protein Sci; 2007 Jan; 16(1):43-51. PubMed ID: 17123961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors.
    Kunze J; Todoroff N; Schneider P; Rodrigues T; Geppert T; Reisen F; Schreuder H; Saas J; Hessler G; Baringhaus KH; Schneider G
    J Chem Inf Model; 2014 Mar; 54(3):987-91. PubMed ID: 24528206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining the multiple protein structure pharmacophore method: consistency across three independent HIV-1 protease models.
    Meagher KL; Lerner MG; Carlson HA
    J Med Chem; 2006 Jun; 49(12):3478-84. PubMed ID: 16759090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models.
    Steindl TM; Schuster D; Laggner C; Chuang K; Hoffmann RD; Langer T
    J Chem Inf Model; 2007; 47(2):563-71. PubMed ID: 17381173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistage virtual screening and identification of novel HIV-1 protease inhibitors by integrating SVM, shape, pharmacophore and docking methods.
    Wei Y; Li J; Chen Z; Wang F; Huang W; Hong Z; Lin J
    Eur J Med Chem; 2015 Aug; 101():409-18. PubMed ID: 26185005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease.
    Li N; Ainsworth RI; Ding B; Hou T; Wang W
    J Chem Inf Model; 2015 Jul; 55(7):1400-12. PubMed ID: 25993532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.
    Qiu X; Zhao GD; Tang LQ; Liu ZP
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2465-8. PubMed ID: 24767846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1.
    Frecer V; Burello E; Miertus S
    Bioorg Med Chem; 2005 Sep; 13(18):5492-501. PubMed ID: 16054372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease.
    Li D; Liu MS; Ji B; Hwang KC; Huang Y
    Chem Biol Drug Des; 2012 Sep; 80(3):440-54. PubMed ID: 22621379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure based drug design for HIV protease: from molecular modeling to cheminformatics.
    Volarath P; Harrison RW; Weber IT
    Curr Top Med Chem; 2007; 7(10):1030-8. PubMed ID: 17508936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting structural effects in HIV-1 protease mutant complexes with flexible ligand docking and protein side-chain optimization.
    Schaffer L; Verkhivker GM
    Proteins; 1998 Nov; 33(2):295-310. PubMed ID: 9779795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease.
    Dewdney TG; Wang Y; Liu Z; Sharma SK; Reiter SJ; Brunzelle JS; Kovari IA; Woster PM; Kovari LC
    Bioorg Med Chem; 2013 Dec; 21(23):7430-4. PubMed ID: 24128815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HIV wild-type and mutant structures via in silico docking against diverse ligand libraries.
    Chang MW; Lindstrom W; Olson AJ; Belew RK
    J Chem Inf Model; 2007; 47(3):1258-62. PubMed ID: 17447753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving binding mode predictions by docking into protein-specifically adapted potential fields.
    Radestock S; Böhm M; Gohlke H
    J Med Chem; 2005 Aug; 48(17):5466-79. PubMed ID: 16107145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors.
    Brik A; Muldoon J; Lin YC; Elder JH; Goodsell DS; Olson AJ; Fokin VV; Sharpless KB; Wong CH
    Chembiochem; 2003 Nov; 4(11):1246-8. PubMed ID: 14613121
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
    Ghosh AK; Kincaid JF; Walters DE; Chen Y; Chaudhuri NC; Thompson WJ; Culberson C; Fitzgerald PM; Lee HY; McKee SP; Munson PM; Duong TT; Darke PL; Zugay JA; Schleif WA; Axel MG; Lin J; Huff JR
    J Med Chem; 1996 Aug; 39(17):3278-90. PubMed ID: 8765511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.